A Two-Part, Randomized, Open-Label, Single Dose, Crossover Clinical Trial to Assess the Relative Bioavailability of a Tablet Compared to a Capsule of GSK3640254 and to Assess the Effect of Food on the GSK3640254 Tablet in Healthy Participants
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Fipravirimat (Primary) ; Fipravirimat (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors ViiV Healthcare
Most Recent Events
- 21 May 2020 Status changed from recruiting to completed.
- 17 Feb 2020 New trial record